---
figid: PMC7511626__fonc-10-01726-g0001
figtitle: Conflicting role of PD-1 and PD-L1 in cancer management
organisms:
- Homo sapiens
- Mus musculus
organisms_ner:
- Mus musculus
- Homo sapiens
- Drosophila melanogaster
pmcid: PMC7511626
filename: fonc-10-01726-g0001.jpg
figlink: pmc/articles/PMC7511626/figure/F1/
number: F1
caption: Conflicting role of PD-1 and PD-L1 in cancer management. (A) In the classical
  understanding of PD-1/PD-L1 regulation, PD-1 expressed on mature cytotoxic T lymphocytes
  reduces anti-tumor cytotoxicity via binding to tumor PD-L1. Both PD-1/PD-L1 CRISPR/Cas9-mediated
  PD-1 knockdown and blockade in T cells result in higher anti-tumor cytotoxicity.
  (B) Recent reports show that PD-1/PD-L1 blockade and/or silencing lead to PI3K/AKT
  and MEK/ERK1/2 pathway activation, thus inducing tumor growth and survival. The
  opposite effect is observed when PD-1/PD-L1 are found overexpressed in cancer cells.
  Figure created using BioRender.
papertitle: 'Commentary: Safety and feasibility of CRISPR-edited T cells in patients
  with refractory non-small-cell lung cancer.'
reftext: Rafael Rosell, et al. Front Oncol. 2020;10:1726.
year: '2020'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.5021021
figid_alias: PMC7511626__F1
figtype: Figure
redirect_from: /figures/PMC7511626__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7511626__fonc-10-01726-g0001.html
  '@type': Dataset
  description: Conflicting role of PD-1 and PD-L1 in cancer management. (A) In the
    classical understanding of PD-1/PD-L1 regulation, PD-1 expressed on mature cytotoxic
    T lymphocytes reduces anti-tumor cytotoxicity via binding to tumor PD-L1. Both
    PD-1/PD-L1 CRISPR/Cas9-mediated PD-1 knockdown and blockade in T cells result
    in higher anti-tumor cytotoxicity. (B) Recent reports show that PD-1/PD-L1 blockade
    and/or silencing lead to PI3K/AKT and MEK/ERK1/2 pathway activation, thus inducing
    tumor growth and survival. The opposite effect is observed when PD-1/PD-L1 are
    found overexpressed in cancer cells. Figure created using BioRender.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Pdcd1
  - Cd274
  - Poli
  - Bcar1
  - Cse1l
  - .na.character
  - ras
  - Hras
  - Kras
  - Rem1
  - Pik3r1
  - Zhx2
  - Pdk1
  - Pdpk1
  - Mdk
  - Akt1
  - Ephb2
  - Mapk1
  - PDCD1
  - RPL17
  - RPL17-C18orf32
  - CD274
  - POLI
  - CSE1L
  - CTNND1
  - BCAR1
  - TMX2-CTNND1
  - KRAS
  - HRAS
  - NRAS
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - PDK1
  - PDPK1
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - AKT1
  - AKT2
  - AKT3
  - EPHB2
  - MAPK1
  - MAPK3
  - PolI
  - cas
  - caz
  - Cse1
  - cass
  - cash
  - Low
  - Ras64B
  - Ras85D
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Raf
  - Dsor1
  - Mtk
  - Akt
  - Erk7
  - rl
  - tumor
  - cytotoxicity
---
